Cancer Pain - Pipeline Review, H1 2017
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cancer Pain - Pipeline Review, H1 2017, provides an overview of the Cancer Pain (Central Nervous System) pipeline landscape.
Cancer pain can be defined as a complex sensation that reflects both damage to the body and the body's response to the damage. Pain may arise due to tumor compressing or infiltrating tissue, from treatments and diagnostic procedures, or from
Read More
- List of Tables
- Number of Products under Development for Cancer Pain, H1 2017
- Number of Products under Development by Companies, H1 2017
- Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
- Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017
- Number of Products under Development by Universities/Institutes, H1 2017
- Products under Development by Companies, H1 2017
- Products under Development by Companies, H1 2017 (Contd..1), H1 2017
- Products under
Read More
- Table of Contents
- Table of Contents 2
- Introduction 5
- Cancer Pain - Overview 6
- Cancer Pain - Therapeutics Development 7
- Cancer Pain - Therapeutics Assessment 17
- Cancer Pain - Companies Involved in Therapeutics Development 27
- Cancer Pain - Drug Profiles 45
- Cancer Pain - Dormant Projects 113
- Cancer Pain - Discontinued Products 116
- Cancer Pain - Product Development Milestones 117
- Appendix 125
Read More